Multiple diseases in the elderly: Therapeutic management and avoidable pitfalls;Polypathologies du sujet age et reponses therapeutiques: Les pieges a eviter

Presse Medicale

Volumn 28, Issue 32, 1999, Pages 1780-1788

  Gonthier, R ^a   Cathebras, P ^b  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DIGOXIN; DIURETIC AGENT; DRUG; MORPHINE; NEUROLEPTIC AGENT; OXYBUTYNIN; PARACETAMOL; PHENOTHIAZINE DERIVATIVE; PRAZOSIN; SULFONAMIDE;

COGNITIVE DEFECT; CREATININE CLEARANCE; DRUG CHOICE; DRUG CLEARANCE; DRUG INDUCED DISEASE; DRUG MISUSE; ELDERLY CARE; HUMAN; MEDICAL DECISION MAKING; MUSCLE HYPOTONIA; ORTHOSTATIC HYPOTENSION; POLYPHARMACY; PRESCRIPTION; REVIEW; RISK MANAGEMENT; SELF MEDICATION; SOMNOLENCE; AGED; DRUG INTERACTION; DRUG THERAPY; FRAIL ELDERLY; PRACTICE GUIDELINE; STANDARD;

AGED; DRUG INTERACTIONS; DRUG THERAPY; FRAIL ELDERLY; HUMANS; PRACTICE GUIDELINES;

EID: 0033598490     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Campbell AJ, Buchner DM. Unstable disability and the fluctuations of frailty. Age Ageing 1997 ; 26:315-8.
2. Campion EW. The oldest old. (Editorials) N Engl J Med 1994 ; 330:1819-20.
3. Moore N, Imbs JL. Effets indésirables des médicaments chez la personne ågée : une analyse de la Banque nationale de cas en pharmacovigilance. Rev Prat 1996 ; 46:396-9.
4. Beers MH, Storries M, Lee C. Potential adverse drug interactions in the emergency room. Ann Intern Med 1990 ; 112:61-4.
5. Fried L, Storer, D, King D, Lodder F. Diagnosis of illness presentation in the elderly. J Am Ceriatr Soc 1991 ; 39:117-23.
6. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998 ; 352:1167-71.
7. Kutner M, Nixon G, Silverstone F. Physicians attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med 1991 ; 151:1950-3.
8. Mc Crory DC, Matchar D, Samoa G, Sanders LL, Prichett LC Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch intern Med 1995 ; 155:277-81.
9. Philbin EF, Santella RN, Rocco TA. Angiotensin - converting enzyme inhibitor use in older patients with heart failure and renal dysfunction. J Am Geriatr Soc 1999 ; 47:302-8.
10. Agence Nationale pour le Développement de l'Evaluation Médicale. Prescription pluri-médicamenteuse chez la personne ågée de plus de 70 ans : polyprescription : risques et règles qui en découlent. In Recommandations et Références Médicales Paris : ANDEM 1995 ; 2:125-48.
11. Queneau P, Chabot JM, Rajaona H, Boissier C Grandmottet P. latrogénie observée en milieu hospitalier. Analyse des causes et propositions pour de nouvelles mesures préventives. Bull Acad Natl Méd 1992 ; 176:651-67.
12. Stewart RB, Caranasos GJ. Medication compliance in the elderly. Med Clin North Ann 1989 ; 73:1551-63.
13. Col NC, Fanale JE, Kranholm P. The role of medication non compliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990 ; 150:841-5.
14. Roblot P, De Bayser L, Banier J, Maréchand R, Becy-Giraudon B. Primum non nocere. Etude prospective de 115 observations de pathologies iatrogènes recueillies en 1 an chez 106 malades. Rev Méd Interne 1994 ; 15:720-6.
15. Morrow D, Leirer V, Sheikh J. Adherence and medications instructions. Review and recommandations. J Am Geriatr Soc 1988; 36:1147-60.
16. Montanat SC, Cusak BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med 1989 ; 321:303-9.
17. Rowe J, Andres R, Tobim J, Norris AH, Shock NW. The effect of age on creatinine clearance in men : a cross sectional and longitudinal study. J Gerontol 1976 ; 31:155-63.
18. Lindeman RD, Tobin J, Shock M. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985 ; 33:278-85.
19. Mimran A. Fonction rénale et vieillissement. Néphrologie 1990 ; 11:275-80.
20. Ryckelynck JP, Hurault De Ligny B. Effets fonctionnels rénaux des anti-inflammatoires non stéroïdiens et des prostaglandines. Néphrologie 1988 ; 9:125-8.
21. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin and nonsteroidal anti inflammatory drug. N Engl J Med 1994; 331:1675-9.
22. Sandler DP, Burr R, Weinberg CR. Nonsteroidal anti inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991 ; 115:165-72.
23. Girgis L, Brooks P. Nonsteroidal anti-inflammatory drugs. Differential use in older patients. Drugs & Aging 1994 ; 4:101-12.
24. Hricik DE, Dunon MJ. Angiotensin converting enzyme inhibitor indiced renal failure : causes, consequences and diagnostic uses. J Am Soc Nephrol 1990 ; 1:845.
25. Devoy MA, Tomson CR, Edmunds ME, Feehally J, Walls J. Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible. J Intern Med 1992 ; 232:493-8.
26. Reid JL, Mc Fadyen RJ, Squire IB, Lees KR. Angiotensin converting enzyme inhibitors in heart failure : blood pressure changes after the first dose. Am Heart J 1993 ; 126:794-7.
27. Charmes JP, Merle L. Les conséquences du vieillissement rénal en thérapeutique. Revue de Gériatrie 1996 ; 21:447-52.
28. Constans T, Back Y, Larnisse F. Protein-energy malnutrition in elderly medical patients. J Am Geriatr Soc 1992 ; 40:263-8.
29. Vittone JL, Ballor DL, Nair KS. Muscle wasting in the elderly. Age et Nutrition 1996 ; 7:96-105.
30. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
31. Lacour B. Créatinine et fonction rénale. Néphrologie 1992 ; 13:73-81.
32. Guillausseau PJ, Fontbonne A, Cahen-Varseaux J, Moulonguet M, Papoz L, Lubetzki J. Creatinine clearance evaluation in routine diabetes practice. Diabetes Research 1988 ; 7:145-8.
33. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989 ; 9:297-301.
34. Greenblatt DJ, Devoll M, Abernethy et al. Reduced clearance of triazolam in old age relation to antipyrine oxiduring capacity. Br J Clin Pharmacol 1983 ; 15:303-9.
35. Iwamoto K, Watanabe J, Araki K et al. Effect of age on hepatic clearance of propanolol in rats. J Pharm Pharmacol 1985; 37:466-70.
36. Vestal RE, Norris AH, Tobin JD, Cohen BH, Shock NW, Andres R. Antipyrine metabolism in man, influence of age, alcohol, caffeine and smoking. Clin Pharmacol Ther 1975 ; 18:425-32.
37. Swift CG, Homeida M, Halliwell M, Roberts CJ. A study of antipyrine in relation to liver size in the elderly. Eur J Clin Pharmacol 1978 ; 14:149-52.
38. Scott RB, Mitchell MC. Aging, alcohol and the liver. J Am Geriatr Soc 1988 ; 36:255-65.
39. Woodhouse KW, Mutch E, Williams FM, Rawlins MD, James OF. The effects of age on paterways of drug metabolism in human liver. Age Ageing 1984 ; 13:328-34.
40. Iber FL, Murphy PA, Connor ES. Age-related changes in the gastrointestinal system. Effects on drug therapy. Drugs & Aging 1994 ; 5:34-48.
41. Lipsitz LA. Orthostatic hypotension in the elderly. N Engl J Med 1989 ; 321:952-7.
42. Hugues FC, Le Jeune Cl, Munera Y. Réponses cardiovasculaires à l'orthostatisme passif et actif de sujets sains en fonction de l'âge. Pathol Biol 1991 ; 39:674-80.
43. Collins KJ, Exton-Smith AN, James MH, Olivier DJ. Functional changes in autonomic nervous responses with ageing. Age Ageing 1980 ; 9:17-24.
44. Bertal O, Buhler FR, Kjowoki W, Lütald BE. Decreased beta adrenoreceptor responsiveness as related to age, blood pressure and plasma catecholamines in patients with essential hypertension. Hypertension 1980 ; 2:130-8.
45. Mets TF. Drug-induced orthostatic hypotension in older patients. Drugs Aging 1995 ; 6:219-28.
46. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people : a systematic review and meta-analysis : I. Psychotropic drugs. J Am Geriatr Soc 1999 ; 47:30-9.
47. Leipzig RM, Cumming RC, Tinetti ME. Drugs and falls in older people : a systematic review and meta-analysis : II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999 ; 47:40-50.
48. Blétry O. Aspects étiologiques des hypotensions orthostatiques. Rev Méd Interne 1992 ; 13:430-7.
49. Campion EW, Avorn J, Reder VA, Olins NJ. Overmedication of the low-weight elderly. Arch Intern Med 1987 ; 147:945-7.
50. Wallace SM, Verbeeck RK. Plasma protein binding of drugs in the elderly. Clin Pharmacokinet 1987 ; 12:41-72.
51. Biour M, Henry JF, Advenier C, Forette F, Cheymol G. Médicaments et patients âgés. In : Pharmacologie Clinique. Paris, Expansion Scientifique Française 1988 : 226-36.
52. Booth FW, Weeden SH, Tseng BS. Effect of aging on human skeletal muscle and motor function. Med Sci Sports Exerc 1994 ; 26:556-60.
53. Lexell J. Ageing and human skeletal muscle : observation from Sweden. Can J Appl Physiol 1993 ; 18:2-18
54. Brooks SV, Faulkner JA. Skeletal muscle weakness in old age : underlying mechanisms. Med Sci Sports Exerc 1994; 26:432-9.
55. Forbes GB, Reina JC. Adult lean body mass declines with age : some longitudinal observations. Metabolism 1970 ; 19:653-63.
56. Novak LP. Aging total body potassium, fat free mass and cell mass in males and females between the ages 18 and 85 years. J Gerontol 1972 ; 27:438-43.
57. Owen JA, Sitar DS, Berger L, Brownell C, Duke PC, Mitenko PA. Age related morphine kinetics, Clin Pharmacol Ther 1983 ; 34:364-8.
58. Morgan DB, Nexton HMV, Schorah CJ, Jewitt MA, Hancock MR, Hullin RP. Abnormal indices of nutrition in the elderly a study of different clinical groups. Age Ageing 1986 ; 15:65-7.
59. Wallace JL, Schwartz RS, Lacroix AZ, Ullman RF, Peralman RA. Involuntary weight loss in older out patients : incidence and clinical significative. J Am Geriatr Soc 1995; 43:329-37.
60. Burns A, Marsh GP, Bender D. Dietary intake and clinical anthropometric and biochemical indices of malnutrition in elderly demented patients and non demented subjects. Psychol Med 1989; 19:383-91.
61. Wolf-Klein GP, Silverstone FA, Levy AP. Nutritional patterns and weight change in Alzheimer patients. Int Psychogeriatr 1992 ; 4:103-11.
62. Wallace SM, Verbeeck RK. Plasma protein binding of drugs in the elderly. Clin Pharmacokinetics 1987 ; 12:41-72.
63. Corti MC, Guralnik JM, Salvie ME, Sorkin JD. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA 1994 ; 272:1036-42.
64. Guillet Ph, Piette F. Pharmacologie du sujet âgé. Rev Prat 1986; 36:581-92.
65. Guralnik JM, Ferrucci L, Simonsick EM, Salvie ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995 ; 332:556-61.
66. Moulias R, Salvatore R, Weill-Engerer S, Lesourd B, Meaume S. Influence des facteurs nutritionnels et inflammatoires sur le métabolisme et la fonction musculaire. Rev de Gériatrie 1994 ; 19:613-8.
67. Cummings RG, Miller JP, Kelsey JL et al. Medications and multiple falls in elderly people : The Saint-Louis oasis study. Age Ageing 1991 ; 20:455-61.
68. Lord SR, Anstey KJ, Williams P, Ward JA. Psychoactive medication use, sensorimotor functions and falls in older women. Br J Clin Pharmacol 1995 ; 39:227-34.
69. Tinetti ME, Williams TF, Mayewski R. Falls risk index for elderly patients based on number of chronic disabilities. Am J Med 1986; 80:429-34.
70. Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment. Ann Intern Med 1987 ; 107:169-73.
71. Starr JM, Deary IJ, Inch S, Cross S, Mac Lennan WJ. Age-associated cognitive declin in healthy old people. Age Ageing 1997 ; 26:295-300.
72. Perry EK. The cholinergic system in old age and Alzheimer's desease. Age Ageing 1980 ; 9:1-8.
73. Albert M, Wolfe J, Laflèche G. Differences in abstraction ability witch age. Psychol Aging 1990 ; 5:64-102.
74. Jacqmin-Gadola H, Fabrigoule C, Commenges D, Dartigues JF. A 5 year longitudinal study of the Mini Mental State examination in normal aging. Am J Epidemiol 1997 ; 145:498-506.
75. Katz IR, Sands LP, Bilker W, Difilippo S, Boyee A, D'Angelo K. Identification of medications that cause cognitive impairment in older people : the case of oxybutynin chloride. J Am Geriatr Soc 1998 ; 46:8-13.
76. Camicioli RM, Kaye JA, Brummel-Smith K. Recognition of neurologic diseases in geriatric inpatients. Acta Neurol Scand 1998 ; 97:265-70.
77. Reifler BV. Pre-dementia. J Am Geriatr Soc 1997 ; 45:776-7.
78. Dérouesné C. Plaintes mnésiques du sujet âgé. Revue du Praticien 1994 ; 44:1432-4.
79. Mc Shane R, Keene J, Gedling K et al. Do neuroleptic drugs hasten cognitive decline in dementia ? Prospective study with necropsy follow up. BMJ 1997 ; 314:266-70.
80. Sellal F. Effets indésirables des anxiolytiques chez les personnes âgées. Rev Fr Psychiatrie Psycho Méd 1997 ; 7:50-3.
81. Jackson RA, Hawa MI, Roshania RD, Sim BM, Disilvio L, Jaspan JB. Influence of aging on hepatic and peripheral glucose metabolism in humans. Diabetes 1988 ; 36:119-28.
82. Jackson RA. Mechanisms of age related glucose intolerance. Diabetes Care 1990 ; 13(Suppl 2):9-19.
83. Ametz BB, Kallner A, Theorell T. The influence of aging on hemoglobin A1C. J Gerontol 1982 ; 37:648-50.
84. Cerami A. Glucose as a mediator of aging. J Am Geriatr Soc 1985 ; 9:626-34.
85. Wang JT, Holt, Jany KT et al. Effect of habitual physical activity on age related glucose intolerance. J Am Geriatr Soc 1989; 37:203-9.
86. Samanta A, Blandford RL, Burden AC, Castleden CM. Glucose tolerance following strokes in the elderly. Age Ageing 1986; 15:111-3.
87. Simmons D, Williams DRR. Diabetes in the elderly : an under-diagnosed condition. Diabetic Mediane 1993 ; 10:264-6.
88. Logie AW, Galloway DB, Petrie JC. Drug interactions and long-term anti-diabetic therapy. Br J Clin Pharmacol 1976 ; 3:1027-32.
89. Seltzer HS. drug-induced hypoglycemia. A review based on 473 cases. Diabetes 1972 ; 21:955-66.
90. Benoît O. Vieillissement et troubles du sommeil. Concours Médical 1988 ; 110:2923-7.
91. Morgan K. Hypnotics in the elderly. What cause for concern ? Drugs 1990 ; 40:688-96.
92. Goldenberg F. Traitement de la somnolence diurne excessive. Lettre du Neurologue 1998 ; 2:65-72.
93. Ministère du Travail et des Affaires Sociales, Secrétariat d'Etat àla Santé et à la Sécurité Sociale. Prescrire et dispenser un médicament à une personne âgée. Guide à l'Intention des Médecins et des Pharmaciens d'Officine Paris 1996: 31 p.
94. Rudberg MA, Barr G, Cassel Ch, Hayward, Sussman EJ, Roizen MF. Guidelines, practice policies and parameters: the case for geriatrics. J Am Geriatr Soc 1994 ; 42:665-9.
95. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991 ; 151:1825-32.
96. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-develling elderly. JAMA 1994 ; 272:292-6.
97. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991 ; 114:956-6.
98. Larny PP. The elderly and drug interactions. J Am Geriatr Soc 1986 ; 34:586-92.
99. Buchner DM, Wagner EH. Preventing frail health. Clin Geriatr Med 1992 ; 8:1-17.
100. Woodhouse KW, Wynne H, Baillie S, James OF, Rawlins MD. Who are the frail elderly ? Quart J Med 1988 ; 68:505-6.
101. Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing home during implementation of the OBRA-87 regulation. JAMA 1994 ; 271:358-63.
102. Schmidt I, Claesson C, Westerholm B, Nilsson L, Svarstad B. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 1998 ; 46:77-82.